Evidence map›Paper›PMID 36673041›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Usefulness of Chromogenic Media with Fluconazole Supplementation for Presumptive Identification of

Alba Ruiz-Gaitán, Ignacio Sigona-Giangreco, José Manuel Pérez-Royo, Victor Garcia-Bustos, Marta García-Hita, Eulogio Valentín-Gómez, Salvador Giner Almaraz, Piet W J de Groot, Javier Pemán

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2026
    Review
  3. Review
  4. Diagnostic Approaches forMicroorganisms · 2025
    Review
  5. Review
  6. Article
  7. Is routine screening forIranian journal of microbiology · 2024
    Article
  8. What Do We Know aboutMicroorganisms · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Alba Ruiz-GaitánDepartment of Clinical Microbiology, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.ORCID 0000-0003-1730-9947
Ignacio Sigona-GiangrecoSevere Infection Research Group, Medical Research Institute La Fe, 46026 Valencia, Spain.ORCID 0000-0001-9357-5257
José Manuel Pérez-RoyoSevere Infection Research Group, Medical Research Institute La Fe, 46026 Valencia, Spain.ORCID 0000-0003-4544-0184
Victor Garcia-BustosSevere Infection Research Group, Medical Research Institute La Fe, 46026 Valencia, Spain.
Marta García-HitaSevere Infection Research Group, Medical Research Institute La Fe, 46026 Valencia, Spain.ORCID 0000-0002-8295-0362
Eulogio Valentín-GómezDepartment of Microbiology and Ecology, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0002-7895-9460
Salvador Giner AlmarazDepartment of Clinical Microbiology, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.
Piet W J de GrootRegional Center for Biomedical Research, Castilla-La Mancha Science & Technology Park, University of Castilla-La Mancha, 02008 Albacete, Spain.ORCID 0000-0002-3112-6947
Javier PemánDepartment of Clinical Microbiology, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain.
Hospital Universitari i Politècnic La Fe · ESLeitat Technological Center · ESUniversitat de València · ESUniversity of Castilla-La Mancha · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction:Candida auris is a major threat to public health. Rapid detection is essential for early treatment and transmission control. The use of chromogenic media allows the presumptive identification of this new species. The aim of this study is to describe the morphological characteristics of C. auris colonies on three commercial chromogenic media. Methods: Nineteen C. auris isolates from different countries/clades and 18 isolates of other species were cultivated in CHROMagarTM Candida Plus, HiCromeTM Candida, CHROMagar-Candida, and fluconazole-supplemented (32 mg/L) CHROMagar-Candida media. Results: On CHROMagarTM Candida Plus and HiCromeTM Candida, C. auris isolates from Colombia, Venezuela, India, Korea, and Japan displayed blue-shaded colonies, while isolates from Spain and Germany exhibited light pink shades with a bluish halo. All isolates showed white to pink colonies on CHROMagar-Candida. On CHROMagar Candida supplemented with fluconazole, whilst C. auris, C. glabrata, or C. krusei showed a similar pink color at 48 h incubation, phenotypic differentiation was possible by the rough, paraffin-like texture or the intense purple color acquired by C. krusei and C. glabrata, respectively. Moreover, in this medium, the presence of C. auris in combination with other species of similar color was not limiting for its early identification, due to this medium selecting only strains resistant to this antifungal. Conclusions: The use of chromogenic media such as CHROMagarTM Candida Plus facilitates a presumptive identification of C. auris. However, this identification can be difficult in the presence of mixed cultures. In these cases, the use of CHROMagarTM Candida medium with 32 mg/L fluconazole offers better performance for the identification of C. auris by inhibiting fluconazole-susceptible strains and selecting rare or high fluconazole MIC (>32 mg/L) isolates.

Indexed as

Candida aurisCHROMagar™ Candida Pluschromogenic mediafluconazole supplementationHiCromeTM Candidayeast identification

Identifiers

PMID36673041
PMCPMC9857578
OpenAlexW4313826684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.